NZ208229A - Antiarrhythmic compositions containing d-sotalol - Google Patents

Antiarrhythmic compositions containing d-sotalol

Info

Publication number
NZ208229A
NZ208229A NZ208229A NZ20822984A NZ208229A NZ 208229 A NZ208229 A NZ 208229A NZ 208229 A NZ208229 A NZ 208229A NZ 20822984 A NZ20822984 A NZ 20822984A NZ 208229 A NZ208229 A NZ 208229A
Authority
NZ
New Zealand
Prior art keywords
sotalol
antiarrhythmic
mammal
composition according
pharmaceutically acceptable
Prior art date
Application number
NZ208229A
Other languages
English (en)
Inventor
A Simon
J A Thomis
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23976573&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ208229(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NZ208229A publication Critical patent/NZ208229A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Light Receiving Elements (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NZ208229A 1983-05-23 1984-05-21 Antiarrhythmic compositions containing d-sotalol NZ208229A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49736883A 1983-05-23 1983-05-23

Publications (1)

Publication Number Publication Date
NZ208229A true NZ208229A (en) 1988-02-12

Family

ID=23976573

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ208229A NZ208229A (en) 1983-05-23 1984-05-21 Antiarrhythmic compositions containing d-sotalol

Country Status (21)

Country Link
EP (1) EP0127435B1 (https=)
JP (1) JPS59222411A (https=)
AT (2) AT386121B (https=)
BE (1) BE899717A (https=)
CA (1) CA1237079A (https=)
CH (1) CH662055A5 (https=)
CY (1) CY1552A (https=)
DE (2) DE3419067A1 (https=)
DK (1) DK161363C (https=)
FI (1) FI842041A7 (https=)
FR (1) FR2548898B1 (https=)
GB (1) GB2141339B (https=)
HK (1) HK74891A (https=)
IT (1) IT1209547B (https=)
LU (1) LU85371A1 (https=)
MY (1) MY100562A (https=)
NL (1) NL8401644A (https=)
NZ (1) NZ208229A (https=)
SE (1) SE468035B (https=)
SG (1) SG41290G (https=)
ZA (1) ZA843871B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69500377T2 (de) 1994-08-19 1997-10-09 Mitsui Toatsu Chemicals Pyrimidin-Dion-Derivate und diese enthaltende antiarrhythmische Zusammensetzungen
ATE189809T1 (de) * 1995-01-10 2000-03-15 Upjohn Co Antiarrhytmische (s)-enantiomere von methansulphonamiden
US5874475A (en) * 1995-12-21 1999-02-23 Pharmacia & Upjohn Company Antiarrhythmic (S)-enantiomers of methanesulfonamides
EP2316468A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US334158A (en) * 1886-01-12 Geoege w
GB993584A (https=) * 1962-01-24

Also Published As

Publication number Publication date
MY100562A (en) 1990-11-15
SE468035B (sv) 1992-10-26
IT8421046A0 (it) 1984-05-22
CY1552A (en) 1991-03-22
DK161363C (da) 1991-12-09
DE3419067C2 (https=) 1989-09-21
FI842041L (fi) 1984-11-24
EP0127435B1 (en) 1991-08-28
IT1209547B (it) 1989-08-30
GB2141339A (en) 1984-12-19
AT386121B (de) 1988-07-11
DE3484971D1 (de) 1991-10-02
FR2548898B1 (fr) 1987-05-15
GB8413217D0 (en) 1984-06-27
BE899717A (fr) 1984-11-22
DK251784A (da) 1984-11-24
GB2141339B (en) 1987-08-26
HK74891A (en) 1991-09-27
ATA170584A (de) 1987-12-15
DK161363B (da) 1991-07-01
DK251784D0 (da) 1984-05-22
FR2548898A1 (fr) 1985-01-18
FI842041A7 (fi) 1984-11-24
SE8402756D0 (sv) 1984-05-22
JPH0377172B2 (https=) 1991-12-09
ATE66603T1 (de) 1991-09-15
CH662055A5 (de) 1987-09-15
EP0127435A3 (en) 1986-07-30
EP0127435A2 (en) 1984-12-05
NL8401644A (nl) 1984-12-17
DE3419067A1 (de) 1984-11-29
CA1237079A (en) 1988-05-24
FI842041A0 (fi) 1984-05-22
SE8402756L (sv) 1984-11-24
SG41290G (en) 1990-08-03
ZA843871B (en) 1985-01-30
JPS59222411A (ja) 1984-12-14
LU85371A1 (fr) 1985-03-21

Similar Documents

Publication Publication Date Title
Holmes et al. Flunarizine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use
RU2188015C2 (ru) Способ ингибирования нейропептида y
DE69327328T2 (de) Verwendund von norastemizol zur behandlung der allergischen rhinitis
JPH08778B2 (ja) アルツハイマー病治療薬
JPH11510828A (ja) 光学的に純粋な（＋）ノルシサプリドを用いた嘔吐および中枢神経系障害の治療方法
US5089526A (en) Antiarrhythmic class III process
EP0127435B1 (en) Antiarrhythmic class iii process
Melville et al. Cardiac responses to epinephrine and norepinephrine during prolonged cholesterol and high fat feeding in rabbits
KR20010024768A (ko) 혈관성 두통에 대한 국소 마취제의 신규 용도
Kantelip et al. Chronotropic and dromotropic effects of atropine and hyoscine methobromide in unanaesthetized dogs
Karow Jr et al. Pharmacology of clinically useful beta-adrenergic blocking drugs
GOLDBERG et al. New investigations of the cardiovascular actions of dopamine
Wright et al. Histamine H1-receptor antagonist activity assessed in conscious dogs
RU2774970C2 (ru) Применение карбаматных соединений для профилактики, облегчения или лечения биполярного расстройства
EP0208335B1 (en) Use of a quinazolinone in the preparation of an anti-vertigo drug and pharmaceutical composition
JPS63145231A (ja) ステロイド化合物を含有する脳機能賦活剤
HK40005640A (en) Use of carbamate compound for preventing or treating fibromyalgia or functional syndrome associated with fibromyalgia
JPH0541603B2 (https=)
AU7252700A (en) Use of norastemizole for the treatment of allergic disorders